A training network for the rational design of the next generation of well-defined glycoconjugate vaccines
GLYCOVAX is a European Training Network (ETN) funded in the framework of H2020 Marie Skłodowska- Curie ITN programme. The GLYCOVAX network aims at the education of promising young scientists who will learn how to rationally design well-defined and innovative glycoconjugate vaccines to improve current preventive therapies and tackle unmet medical needs. GLYCOVAX is based on a profound interaction between the academic and industrial sectors, involving 9 academic groups and 2 industrial partners with complementary expertise in chemical/enzymatic synthesis of carbohydrates, conjugation techniques, high throughput screening technology, structural glycobiology, vaccinology and immunology. In this highly multidisciplinary environment 14 ESRs will be trained in the growing field of glycoscience and vaccinology, enriching their skills and combining different state-of-the-art methodologies for the rational design of innovative glycoconjugates.
All the selected students will be involved in a highly stimulating training programme, both at the local and at the network-wide level. The training programme comprises: